Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
2.390
-0.020 (-0.83%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Earnings Outlook For Aytu BioPharma
September 26, 2023
Via
Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
September 13, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 21, 2023
Via
Benzinga
Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
June 13, 2023
Via
ACCESSWIRE
Aytu BioPharma: Q3 Earnings Insights
May 11, 2023
Via
Benzinga
A Preview Of Aytu BioPharma's Earnings
May 10, 2023
Via
Benzinga
Aytu BioPharma Announces Approval of Adzenys XR-ODT(R)Manufacturing Site Transfer
April 27, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Aytu BioPharma's Return On Capital Employed Insights
February 22, 2023
Via
Benzinga
Aytu BioPharma Reports Second Quarter of Fiscal Year 2023
February 21, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 31, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
July 10, 2023
Via
ACCESSWIRE
Star Equity Holdings And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
June 16, 2023
The Dow Jones closed higher by over 400 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Aytu to Participate in the Maxim Group Virtual Healthcare Conference
June 14, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
June 09, 2023
Via
ACCESSWIRE
AYTU Stock Earnings: Aytu Misses EPS, Revenue Estimates
May 11, 2023
AYTU stock earnings show Aytu Biopharma missing earnings per share and revenue estimates for the fiscal third quarter.
Via
InvestorPlace
Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
May 11, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
May 04, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 02, 2023
Via
Benzinga
Why BlackBerry Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
May 02, 2023
Gainers Leju Holdings Limited (NYSE: LEJU) gained 103.7% to $7.25 in pre-market trading after jumping around 97% on Monday .
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 02, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
Aytu BioPharma Subleases a Portion of Its Manufacturing Facility
May 01, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 27, 2023
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023
February 21, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Delayed Filing of Second Quarter Fiscal 2023 Financial Results
February 14, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit